B. Farisogullari Et Al. , "Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?," Internal and emergency medicine , vol.17, no.6, pp.1599-1608, 2022
Farisogullari, B. Et Al. 2022. Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?. Internal and emergency medicine , vol.17, no.6 , 1599-1608.
Farisogullari, B., Cuceoglu, M., Oral, H., Yardimci, G. K., Bilginer, Y., Ozen, S., ... Karadag, O.(2022). Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?. Internal and emergency medicine , vol.17, no.6, 1599-1608.
Farisogullari, Bayram Et Al. "Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?," Internal and emergency medicine , vol.17, no.6, 1599-1608, 2022
Farisogullari, Bayram Et Al. "Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?." Internal and emergency medicine , vol.17, no.6, pp.1599-1608, 2022
Farisogullari, B. Et Al. (2022) . "Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?." Internal and emergency medicine , vol.17, no.6, pp.1599-1608.
@article{article, author={Bayram Farisogullari Et Al. }, title={Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?}, journal={Internal and emergency medicine}, year=2022, pages={1599-1608} }